BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection 2021;49:15-28. [PMID: 32860214 DOI: 10.1007/s15010-020-01509-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee RU, Glickman GL. Sleep, Circadian Health and Melatonin for Mitigating COVID-19 and Optimizing Vaccine Efficacy. Front Neurosci 2021;15:711605. [PMID: 34489630 DOI: 10.3389/fnins.2021.711605] [Reference Citation Analysis]
2 Virág A, Túri G. The impact of the COVID-19 pandemic on the European Union’s public health policy. Politics in Central Europe 2021;17:651-74. [DOI: 10.2478/pce-2021-0035] [Reference Citation Analysis]
3 Yang HS, Racine-Brzostek SE, Karbaschi M, Yee J, Dillard A, Steel PAD, Lee WS, McDonough KA, Qiu Y, Ketas TJ, Francomano E, Klasse PJ, Hatem L, Westblade LF, Wu H, Chen H, Zuk R, Tan H, Girardin R, Dupuis AP, Payne AF, Moore JP, Cushing MM, Chadburn A, Zhao Z. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients. medRxiv 2020:2020. [PMID: 33236020 DOI: 10.1101/2020.11.19.20235044] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Yang HS, Racine-Brzostek SE, Karbaschi M, Yee J, Dillard A, Steel PAD, Lee WT, McDonough KA, Qiu Y, Ketas TJ, Francomano E, Klasse PJ, Hatem L, Westblade L, Wu H, Chen H, Zuk R, Tan H, Girardin RC, Dupuis AP 2nd, Payne AF, Moore JP, Cushing MM, Chadburn A, Zhao Z. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients. Biosens Bioelectron 2021;178:113008. [PMID: 33515984 DOI: 10.1016/j.bios.2021.113008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Nwosu K, Fokam J, Wanda F, Mama L, Orel E, Ray N, Meke J, Tassegning A, Takou D, Mimbe E, Stoll B, Guillebert J, Comte E, Keiser O, Ciaffi L. SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon. Nat Commun 2021;12:5851. [PMID: 34615863 DOI: 10.1038/s41467-021-25946-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Charoenngam N, Shirvani A, Holick MF. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocr Pract 2021;27:484-93. [PMID: 33744444 DOI: 10.1016/j.eprac.2021.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
7 Al Kassaa I, El Omari S, Abbas N, Papon N, Drider D, Kassem II, Osman M. High association of COVID-19 severity with poor gut health score in Lebanese patients. PLoS One 2021;16:e0258913. [PMID: 34673813 DOI: 10.1371/journal.pone.0258913] [Reference Citation Analysis]
8 Possari RY, Andrade-Gomes HJ, Mello VC, Galdeano EA, Aguiar-Filho LF, Bittencourt MS, Ponte EV, Bertoche LR, Caio LRS, Rodrigues JD, Alcantara FB, Freitas MAC, Sarinho JCGC, Cervigne NK, Rodrigues WM, Aprahamian I. Association of coronary calcification with prognosis of Covid-19 patients without known heart disease. Braz J Med Biol Res 2021;54:e11681. [PMID: 34878066 DOI: 10.1590/1414-431X2021e11681] [Reference Citation Analysis]
9 Ratheesh M, Sunil S, Sheethal S, Jose SP, Sandya S, Ghosh OSN, Rajan S, Jagmag T, Tilwani J. Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm. Inflammopharmacol. [DOI: 10.1007/s10787-021-00911-x] [Reference Citation Analysis]
10 Navarro KM, Clark KA, Hardt DJ, Reid CE, Lahm PW, Domitrovich JW, Butler CR, Balmes JR. Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line. Sci Total Environ 2021;760:144296. [PMID: 33341613 DOI: 10.1016/j.scitotenv.2020.144296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chuntamongkol R, Meen R, Nash S, Ohly NE, Clarke J, Holloway N. Resuming elective orthopaedic services during the COVID-19 pandemic : our experience. Bone Jt Open 2021;2:951-7. [PMID: 34783253 DOI: 10.1302/2633-1462.211.BJO-2021-0080.R1] [Reference Citation Analysis]
12 Tabuti NIM, Pellizzari C, Carrascossi H, Calice-Silva V, Figueiredo A, Gordon GM, Biangini G, Rodrigues ME, Dias DB, Silva DRD, Moraes TP. Impact of telemedicine on metabolic control and hospitalization of peritoneal dialysis patients during the COVID-19 pandemic: a national multicentric cohort study. J Bras Nefrol 2022:S0101-28002022005015402. [PMID: 35199824 DOI: 10.1590/2175-8239-JBN-2021-0113] [Reference Citation Analysis]
13 Barh D, Aljabali AA, Tambuwala MM, Tiwari S, Serrano-Aroca Á, Alzahrani KJ, Silva Andrade B, Azevedo V, Ganguly NK, Lundstrom K. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management. Biomedicines 2021;9:556. [PMID: 34067609 DOI: 10.3390/biomedicines9050556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Endres F, Spiro JE, Bolt TA, Tufman A, Ockert B, Helfen T, Gilbert F, Holzapfel BM, Böcker W, Siebenbürger G. One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patient. Infection 2021. [PMID: 34625910 DOI: 10.1007/s15010-021-01711-9] [Reference Citation Analysis]
15 Meyer M, Constancias F, Worth C, Meyer A, Muller M, Boussuge A, Kaltenbach G, Schmitt E, Chayer S, Velay A, Vogel T, Fafi-Kremer S, Karcher P. Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds. Geroscience 2022. [PMID: 35394604 DOI: 10.1007/s11357-022-00546-y] [Reference Citation Analysis]
16 Mahmood ZS, Fadhil HY, Abdul Hussein TA, Ad'hiah AH. Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients. Meta Gene 2022;:101014. [PMID: 35036327 DOI: 10.1016/j.mgene.2022.101014] [Reference Citation Analysis]
17 Ong JS, Gharahkhani P, Vaughan TL, Whiteman D, Kendall BJ, MacGregor S. Assessing the genetic relationship between gastro-esophageal reflux disease and risk of COVID-19 infection. Hum Mol Genet 2021:ddab253. [PMID: 34553760 DOI: 10.1093/hmg/ddab253] [Reference Citation Analysis]
18 Guarino M, Perna B, Remelli F, Cuoghi F, Cesaro AE, Spampinato MD, Maritati M, Contini C, De Giorgio R. A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA. Microorganisms 2022;10:806. [DOI: 10.3390/microorganisms10040806] [Reference Citation Analysis]
19 Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, Labrique A, Mohan D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One 2021;16:e0247461. [PMID: 33661992 DOI: 10.1371/journal.pone.0247461] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
20 Keddy KH, Migliori GB, Van Der Walt M. Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis. Lancet Glob Health 2020;8:e1357-8. [PMID: 33069299 DOI: 10.1016/S2214-109X(20)30413-7] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Chilunga FP, Coyer L, Collard D, Leenstra T, Galenkamp H, Agyemang C, Prins M, Stronks K. COVID-19 Impacts Across Multiple Life Domains of Vulnerable Socio-Demographic Groups Including Migrants: A Descriptive Cross-Sectional Study. Int J Public Health 2022;67:1604665. [DOI: 10.3389/ijph.2022.1604665] [Reference Citation Analysis]
22 Zirpe K, Pote P, Deshmukh A, Gurav SK, Tiwari AM, Suryawanshi P. A Retrospective Analysis of Risk Factors of COVID-19 Associated Mucormycosis and Mortality Predictors: A Single-Center Study. Cureus 2021;13:e18718. [PMID: 34790473 DOI: 10.7759/cureus.18718] [Reference Citation Analysis]
23 Boccardi V. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19. Nat Rev Endocrinol 2021;17:189. [PMID: 33452491 DOI: 10.1038/s41574-021-00466-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Emsen A, Sumer S, Tulek B, Cizmecioglu H, Vatansev H, Goktepe MH, Kanat F, Koksal Y, Arslan U, Artac H. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19. Scand J Immunol 2021;:e13108. [PMID: 34625989 DOI: 10.1111/sji.13108] [Reference Citation Analysis]
25 Ableidinger S, Nierwetberg F, Holzinger B. Dreams and nightmares during the pandemic. Somnologie (Berl) 2022;:1-5. [PMID: 35528045 DOI: 10.1007/s11818-022-00351-x] [Reference Citation Analysis]
26 Meguid NA, Nashaat NH, Abdallah HR, Hemimi M, Elnahry A, El-hariri HM, Elsaeid A. Influence of COVID-19 pandemic lockdown on a sample of Egyptian children with Down syndrome. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00280-2] [Reference Citation Analysis]
27 Chang KP, Reynolds JM, Liu Y, He JJ. Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19? Vaccines 2022;10:248. [DOI: 10.3390/vaccines10020248] [Reference Citation Analysis]
28 Almudarra S, Kamel S, Saleh E, Alaswad R, Alruwaily A, Almowald S, Alqunaibet AM, Almudiaheem A, Almutlaq H, Alserehi H, Almalki S, Bahlaq MA, Alsahafi AJ, Alsaif F, Khojah AT, Al-Tawfiq JA, Asiri SI, Assiri A, Jokhdar H. High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia. Infection 2021. [PMID: 34881415 DOI: 10.1007/s15010-021-01726-2] [Reference Citation Analysis]
29 Jean-Mignard E, De Luna G, Pascal L, Agouti I, Thuret I. SARS-CoV-2 infection in patients with β-thalassemia: The French experience. Transfus Clin Biol 2021:S1246-7820(21)00089-6. [PMID: 34217815 DOI: 10.1016/j.tracli.2021.06.007] [Reference Citation Analysis]
30 Lange B, Welker S, Kittel M, Jabbour C, Reindl W, Walter T, Heininger A. A case series of severe breakthrough infections observed in nine patients with COVID-19 in a southwestern German university hospital. Infection 2022. [PMID: 35294729 DOI: 10.1007/s15010-022-01797-9] [Reference Citation Analysis]
31 Li CX, Gao J, Zhang Z, Chen L, Li X, Zhou M, Wheelock ÅM. Multiomics integration-based molecular characterizations of COVID-19. Brief Bioinform 2021:bbab485. [PMID: 34864875 DOI: 10.1093/bib/bbab485] [Reference Citation Analysis]
32 Suh HJ, Lee E, Park SW. Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization. J Korean Med Sci 2021;36:e139. [PMID: 34002553 DOI: 10.3346/jkms.2021.36.e139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Hammami AS, Jellazi M, Mahjoub L, Fedhila M, Ouali S. Psychological Impact of the COVID-19 Pandemic on Healthcare Professionals in Tunisia: Risk and Protective Factors. Front Psychol 2021;12:754047. [PMID: 34970189 DOI: 10.3389/fpsyg.2021.754047] [Reference Citation Analysis]
34 Bustos-Vázquez E, Padilla-González E, Reyes-Gómez D, Carmona-Ramos MC, Monroy-Vargas JA, Benítez-Herrera AE, Meléndez-Mier G. Survival of COVID-19 with Multimorbidity Patients. Healthcare (Basel) 2021;9:1423. [PMID: 34828470 DOI: 10.3390/healthcare9111423] [Reference Citation Analysis]
35 Morse J, Gay W, Korwek KM, McLean LE, Poland RE, Guy J, Sands K, Perlin JB. Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients. Endocrinol Diabetes Metab 2021;4:e00291. [PMID: 34505406 DOI: 10.1002/edm2.291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Prasun P. COVID-19: A Mitochondrial Perspective. DNA Cell Biol 2021;40:713-9. [PMID: 33872068 DOI: 10.1089/dna.2020.6453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wong KC, Xiang Y, Yin L, So HC. Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach. JMIR Public Health Surveill 2021;7:e29544. [PMID: 34591027 DOI: 10.2196/29544] [Reference Citation Analysis]
38 Messina F, Giombini E, Montaldo C, Sharma AA, Zoccoli A, Sekaly RP, Locatelli F, Zumla A, Maeurer M, Capobianchi MR, Lauria FN, Ippolito G. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. Cell Death Dis 2021;12:788. [PMID: 34385425 DOI: 10.1038/s41419-021-03881-8] [Reference Citation Analysis]
39 Ghare Naz MS, Banaei M, Dashti S, Tehrani FR. An overview of sex hormones in relation to SARS-CoV-2 infection. Future Virol 2021. [PMID: 34306167 DOI: 10.2217/fvl-2021-0058] [Reference Citation Analysis]
40 Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M, Jolly C, Towers GJ. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J 2021;40:e107826. [PMID: 34101213 DOI: 10.15252/embj.2021107826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R. Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial. J Infect Chemother 2021;27:1743-9. [PMID: 34483029 DOI: 10.1016/j.jiac.2021.08.021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gohari K, Kazemnejad A, Sheidaei A, Hajari S. Clustering of countries according to the COVID-19 incidence and mortality rates. BMC Public Health 2022;22:632. [PMID: 35365101 DOI: 10.1186/s12889-022-13086-z] [Reference Citation Analysis]
43 Dopazo J, Maya-Miles D, García F, Lorusso N, Calleja MÁ, Pareja MJ, López-Miranda J, Rodríguez-Baño J, Padillo J, Túnez I, Romero-Gómez M. Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System. J Pers Med 2021;11:475. [PMID: 34073493 DOI: 10.3390/jpm11060475] [Reference Citation Analysis]
44 Deng J, Heybati K, Ramaraju HB, Zhou F, Rayner D, Heybati S. Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis. Infection 2022. [PMID: 35438413 DOI: 10.1007/s15010-022-01825-8] [Reference Citation Analysis]
45 Weidinger C, Hegazy AN, Glauben R, Siegmund B. COVID-19-from mucosal immunology to IBD patients. Mucosal Immunol 2021;14:566-73. [PMID: 33608656 DOI: 10.1038/s41385-021-00384-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in Viral Infections in the Intensive Care Unit. Front Med (Lausanne) 2021;8:575580. [PMID: 33708775 DOI: 10.3389/fmed.2021.575580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Lee JY, Lee JY, Ko JH, Hyun M, Kim HA, Cho S, Lee YD, Song J, Shin S, Peck KR. Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease. Front Immunol 2021;12:772320. [PMID: 34899724 DOI: 10.3389/fimmu.2021.772320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Alberca RW, Lima JC, de Oliveira EA, Gozzi-Silva SC, Ramos YÁL, Andrade MMS, Beserra DR, Oliveira LM, Branco ACCC, Pietrobon AJ, Pereira NZ, Teixeira FME, Fernandes IG, Duarte AJDS, Benard G, Sato MN. COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients. Front Physiol 2020;11:637627. [PMID: 33584342 DOI: 10.3389/fphys.2020.637627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Arjmand B, Roudsari PP, Alavi-Moghadam S, Rezaei-Tavirani M, Tayanloo-Beik A, Mehrdad N, Adibi H, Larijani B. Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19. Regen Eng Transl Med 2021;:1-15. [PMID: 34746370 DOI: 10.1007/s40883-021-00234-x] [Reference Citation Analysis]
50 Pourani MR, Ganji R, Dashti T, Dadkhahfar S, Gheisari M, Abdollahimajd F, Dadras MS. [Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis]. Actas Dermosifiliogr (Engl Ed) 2021. [PMID: 34565802 DOI: 10.1016/j.ad.2021.08.004] [Reference Citation Analysis]
51 Bormann M, van de Sand L, Witzke O, Krawczyk A. Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2. Klin Monbl Augenheilkd 2021;238:569-78. [PMID: 34020485 DOI: 10.1055/a-1423-8961] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Zhang J, Dong X, Liu G, Gao Y. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-022-08921-5] [Reference Citation Analysis]
53 Moreland A, Gillezeau C, Alpert N, Taioli E. Assessing influenza vaccination success to inform COVID-19 vaccination campaign. J Med Virol 2021. [PMID: 34590732 DOI: 10.1002/jmv.27368] [Reference Citation Analysis]
54 Manna PR, Gray ZC, Reddy PH. Healthy Immunity on Preventive Medicine for Combating COVID-19. Nutrients 2022;14:1004. [DOI: 10.3390/nu14051004] [Reference Citation Analysis]
55 Rios do Vale NM, Latini FRM, Arnoni CP, Parreira RM, Girão MJBC, Cortez AJP, Bonetti TCDS. Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: a cross-sectional blood donors-based study. Clinics 2022. [DOI: 10.1016/j.clinsp.2022.100016] [Reference Citation Analysis]
56 Ratcliffe J, Kanaan M, Galdas P. Men and loneliness in the Covid-19 pandemic: Insights from an interview study with UK-based men. Health Soc Care Community 2022. [PMID: 35122333 DOI: 10.1111/hsc.13746] [Reference Citation Analysis]
57 Nikoloski Z, Alqunaibet AM, Alfawaz RA, Almudarra SS, Herbst CH, El-Saharty S, Alsukait R, Algwizani A. Covid-19 and non-communicable diseases: evidence from a systematic literature review. BMC Public Health 2021;21:1068. [PMID: 34090396 DOI: 10.1186/s12889-021-11116-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Restar AJ, Garrison-Desany HM, Adamson T, Childress C, Millett G, Jarrett BA, Howell S, Glick JL, Beckham SW, Baral S. HIV treatment engagement in the context of COVID-19: an observational global sample of transgender and nonbinary people living with HIV. BMC Public Health 2021;21:901. [PMID: 33980193 DOI: 10.1186/s12889-021-10977-5] [Reference Citation Analysis]
59 Mohanraj D, Baldwin S, Singh S, Gordon A, Whitelegg A. Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104501] [Reference Citation Analysis]
60 Ren L, Wang Y, Zhong J, Li X, Xiao Y, Li J, Yang J, Fan G, Guo L, Shen Z, Kang L, Shi L, Li Q, Li J, Di L, Li H, Wang C, Wang Y, Wang X, Zou X, Rao J, Zhang L, Wang J, Huang Y, Cao B, Wang J, Li M. Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19. Am J Respir Crit Care Med 2021;204:1379-90. [PMID: 34534435 DOI: 10.1164/rccm.202103-0814OC] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Shoaib N, Noureen N, Munir R, Shah FA, Ishtiaq N, Jamil N, Batool R, Khalid M, Khan I, Iqbal N, Zaidi N. COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes. PLoS One 2021;16:e0255999. [PMID: 34379690 DOI: 10.1371/journal.pone.0255999] [Reference Citation Analysis]
62 Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci 2021;90:284-92. [PMID: 34275565 DOI: 10.1016/j.jocn.2021.06.016] [Reference Citation Analysis]
63 Cook JR, Ausiello J. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19. Rev Endocr Metab Disord 2021. [PMID: 34195965 DOI: 10.1007/s11154-021-09663-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Baynouna AlKetbi LM, Nagelkerke N, Abdelbaqi H, ALBlooshi F, AlSaedi M, Almansoori S, AlNuaimi R, AlKhoori A, AlAryani A, AlShamsi M, Kayani F, Alblooshi N, AlKhajeh S, AlFalahi J, AlAmeri S, AlDhahei S. Risk Factors for SARS-CoV-2 Infection Severity in Abu Dhabi. J Epidemiol Glob Health 2021. [PMID: 34734381 DOI: 10.1007/s44197-021-00006-4] [Reference Citation Analysis]
65 Cao BL, Brewer O, Cross AR. Emphysematous cystitis with bilateral pyelonephritis in a pediatric patient with COVID-19. BMJ Case Rep 2022;15:e245779. [PMID: 35115329 DOI: 10.1136/bcr-2021-245779] [Reference Citation Analysis]
66 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 54] [Article Influence: 17.5] [Reference Citation Analysis]
67 Gil-Etayo FJ, Suàrez-Fernández P, Cabrera-Marante O, Arroyo D, Garcinuño S, Naranjo L, Pleguezuelo DE, Allende LM, Mancebo E, Lalueza A, Díaz-Simón R, Paz-Artal E, Serrano A. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression. Front Cell Infect Microbiol 2021;11:624483. [PMID: 33718270 DOI: 10.3389/fcimb.2021.624483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
68 Ahmed AA, Ad'hiah AH. Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19). Cytokine 2021;148:155702. [PMID: 34534925 DOI: 10.1016/j.cyto.2021.155702] [Reference Citation Analysis]
69 [DOI: 10.1101/2020.10.12.20211573] [Reference Citation Analysis]
70 Cagna DR, Donovan TE, McKee JR, Eichmiller F, Metz JE, Albouy JP, Marzola R, Murphy KG, Troeltzsch M. Annual review of selected scientific literature: A report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry. J Prosthet Dent 2021;126:276-359. [PMID: 34489050 DOI: 10.1016/j.prosdent.2021.06.014] [Reference Citation Analysis]
71 Neuberger M, Jungbluth A, Irlbeck M, Streitparth F, Burian M, Kirchner T, Werner J, Rudelius M, Knösel T. Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients. Infection 2022. [PMID: 35182354 DOI: 10.1007/s15010-022-01769-z] [Reference Citation Analysis]
72 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
73 Tsoungui Obama HCJ, Adil Mahmoud Yousif N, Alawam Nemer L, Ngougoue Ngougoue PM, Ngwa GA, Teboh-Ewungkem M, Schneider KA. Preventing COVID-19 spread in closed facilities by regular testing of employees-An efficient intervention in long-term care facilities and prisons? PLoS One 2021;16:e0249588. [PMID: 33886605 DOI: 10.1371/journal.pone.0249588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
74 Berezina TN, Rybtsov S. Acceleration of Biological Aging and Underestimation of Subjective Age Are Risk Factors for Severe COVID-19. Biomedicines 2021;9:913. [PMID: 34440116 DOI: 10.3390/biomedicines9080913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Shafrir A, Benson AA, Katz LH, Hershcovici T, Bitan M, Paltiel O, Calderon-margalit R, Safadi R, Shauly-aharonov M. The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study. Front Pharmacol 2022;13:791074. [DOI: 10.3389/fphar.2022.791074] [Reference Citation Analysis]
76 Jarai BM, Stillman Z, Bomb K, Kloxin AM, Fromen CA. Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19. ACS Biomater Sci Eng 2021;7:1742-64. [PMID: 33356134 DOI: 10.1021/acsbiomaterials.0c01287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Khadem H, Nemat H, Eissa MR, Elliott J, Benaissa M. COVID-19 mortality risk assessments for individuals with and without diabetes mellitus: Machine learning models integrated with interpretation framework. Computers in Biology and Medicine 2022;144:105361. [DOI: 10.1016/j.compbiomed.2022.105361] [Reference Citation Analysis]
78 Can B, Senturk Durmus N, Olgun Yıldızeli S, Kocakaya D, Ilhan B, Tufan A. Nutrition risk assessed by Nutritional Risk Screening 2002 is associated with in-hospital mortality in older patients with COVID-19. Nutr Clin Pract 2022. [PMID: 35488891 DOI: 10.1002/ncp.10860] [Reference Citation Analysis]
79 Magalhães NS, Savino W, Silva PMR, Martins MA, Carvalho VF. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients. Front Med (Lausanne) 2021;8:644751. [PMID: 34458281 DOI: 10.3389/fmed.2021.644751] [Reference Citation Analysis]
80 Bats ML, Rucheton B, Fleur T, Orieux A, Chemin C, Rubin S, Colombies B, Desclaux A, Rivoisy C, Mériglier E, Rivière E, Boyer A, Gruson D, Pellegrin I, Trimoulet P, Garrigue I, Alkouri R, Dupin C, Moreau-Gaudry F, Bedel A, Dabernat S. Covichem: A biochemical severity risk score of COVID-19 upon hospital admission. PLoS One 2021;16:e0250956. [PMID: 33956870 DOI: 10.1371/journal.pone.0250956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Syundyukov E, Mednis M, Zaharenko L, Pildegovica E, Danovska I, Kistkins S, Seidmann A, Benis A, Pirags V, Tzivian L. Data-Driven Decision Making and Proactive Citizen-Scientist Communication: A Cross-Sectional Study on COVID-19 Vaccination Adherence. Vaccines (Basel) 2021;9:1384. [PMID: 34960129 DOI: 10.3390/vaccines9121384] [Reference Citation Analysis]
82 Kucher AN, Koroleva IA, Zarubin AA, Nazarenko MS. MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features. Mol Biol 2022;56:29-45. [DOI: 10.1134/s0026893322010034] [Reference Citation Analysis]
83 Tourkmani AM, Rsheed AMB, Aleissa MS, Alqahtani SM, Alotaibi AF, Almujil MS, Alkhashan IH, Alnassar TN, Alotaibi MN, Alrasheedy AA. Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry. Vaccines 2022;10:310. [DOI: 10.3390/vaccines10020310] [Reference Citation Analysis]
84 Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, Mainali S, Bassetti C, Suarez JI, McNett M; GCS-NeuroCOVID Consortium and ENERGY Consortium. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open 2021;4:e2112131. [PMID: 33974053 DOI: 10.1001/jamanetworkopen.2021.12131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
85 Heubner L, Hattenhauer S, Güldner A, Petrick P, Roessler M, Schmitt J, Schneider R, Held HC, Mehrholz J, Bodechtel U, Ragaller M, Koch T, Spieth PM. Characteristics and outcomes of sepsis patients with and without COVID-19. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.05.008] [Reference Citation Analysis]
86 Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: A syndemic complicated by COVID-19. Med Clin (Engl Ed) 2021;157:288-93. [PMID: 34541325 DOI: 10.1016/j.medcle.2021.04.006] [Reference Citation Analysis]
87 Singh A, Bhardwaj A, Ravichandran N, Malhotra M. Surviving COVID-19 and multiple complications post total laryngectomy. BMJ Case Rep 2021;14:e244277. [PMID: 34321272 DOI: 10.1136/bcr-2021-244277] [Reference Citation Analysis]
88 Fan X, Liu Z, Poulsen KL, Wu X, Miyata T, Dasarathy S, Rotroff DM, Nagy LE. Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank. Nutrients 2021;13:1592. [PMID: 34068824 DOI: 10.3390/nu13051592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Venkatakrishnan AJ, Pawlowski C, Zemmour D, Hughes T, Anand A, Berner G, Kayal N, Puranik A, Conrad I, Bade S, Barve R, Sinha P, O'Horo JC, Badley AD, Halamka J, Soundararajan V. Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications. NPJ Digit Med 2021;4:117. [PMID: 34315980 DOI: 10.1038/s41746-021-00484-7] [Reference Citation Analysis]
90 Kurzhals JK, Klee G, Busch H, Hagelstein V, Zillikens D, Terheyden P, Langan EA. The impact of the Covid-19 pandemic on quality of life in skin cancer patients. PLoS One 2021;16:e0255501. [PMID: 34407086 DOI: 10.1371/journal.pone.0255501] [Reference Citation Analysis]
91 Vilella A, Trilla A. The COVID-19 Pandemic-an Epidemiological Perspective. Curr Allergy Asthma Rep 2021;21:29. [PMID: 33907920 DOI: 10.1007/s11882-021-01007-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Cosentino G, Todisco M, Hota N, Della Porta G, Morbini P, Tassorelli C, Pisani A. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review. Eur J Neurol 2021. [PMID: 34339563 DOI: 10.1111/ene.15045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Vitiello A, Ferrara F. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc Toxicol 2021;21:781-9. [PMID: 34255300 DOI: 10.1007/s12012-021-09674-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Jergović M, Coplen CP, Uhrlaub JL, Nikolich-Žugich J. Immune response to COVID-19 in older adults. J Heart Lung Transplant 2021:S1053-2498(21)02303-2. [PMID: 34140221 DOI: 10.1016/j.healun.2021.04.017] [Reference Citation Analysis]
95 Matuk J, Guo X. Shape-restricted estimation and spatial clustering of COVID-19 infection rate curves. Spat Stat 2021;:100546. [PMID: 34703754 DOI: 10.1016/j.spasta.2021.100546] [Reference Citation Analysis]
96 Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: a syndemic complicated by COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00208-6. [PMID: 34049681 DOI: 10.1016/j.medcli.2021.04.004] [Reference Citation Analysis]
97 Schöning V, Liakoni E, Baumgartner C, Exadaktylos AK, Hautz WE, Atkinson A, Hammann F. Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital. J Transl Med 2021;19:56. [PMID: 33546711 DOI: 10.1186/s12967-021-02720-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
98 Gur E, Levy D, Topaz G, Naser R, Wand O, Kitay-Cohen Y, Benchetrit S, Sarel E, Cohen-Hagai K. Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19. Clin Exp Nephrol 2022. [PMID: 35230569 DOI: 10.1007/s10157-022-02180-6] [Reference Citation Analysis]
99 [DOI: 10.1101/2020.12.21.20248610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Wierz M, Sauerbrei B, Wandernoth P, Kriegsmann M, Casadonte R, Kriegsmann K, Kriegsmann J. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue. Viruses 2022;14:604. [DOI: 10.3390/v14030604] [Reference Citation Analysis]
101 Slattery B, Ackerman L, Jagadamma KC. Service evaluation of telehealth in a physiotherapy musculoskeletal setting: Patient outcomes and results from risk stratification. Musculoskeletal Care 2022. [PMID: 35220671 DOI: 10.1002/msc.1623] [Reference Citation Analysis]
102 Amir G, Rotstein A, Razon Y, Beyersdorf GB, Barak-Corren Y, Godfrey ME, Lakovsky Y, Yaeger-Yarom G, Yarden-Bilavsky H, Birk E. CMR Imaging 6 Months After Myocarditis Associated with the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Cardiol 2022. [PMID: 35320390 DOI: 10.1007/s00246-022-02878-0] [Reference Citation Analysis]
103 Kulkarni-Munje A, Palkar S, Shrivastava S, Lalwani S, Mishra AC, Arankalle VA. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity. Immun Inflamm Dis 2021;9:419-34. [PMID: 33452858 DOI: 10.1002/iid3.402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
104 Veerabathiran R, Ragunath B, Kaviarasan V, Mohammed V, Ahmed SSSJ. Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity. Bull Natl Res Cent 2021;45:79. [PMID: 33907373 DOI: 10.1186/s42269-021-00540-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Kilic G, Bulut O, Jaeger M, Ter Horst R, Koeken VACM, Moorlag SJCFM, Mourits VP, de Bree C, Domínguez-Andrés J, Joosten LAB, Netea MG. The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men. Front Immunol 2021;12:720090. [PMID: 34434199 DOI: 10.3389/fimmu.2021.720090] [Reference Citation Analysis]
106 Gutata D, Alemu ZA. Factors Associated for COVID19 Severity Among Patients Treated at Selgalu Treatment Center Assosa in Ethiopia: A Case-Control Study. Int J Gen Med 2022;15:3303-13. [PMID: 35355795 DOI: 10.2147/IJGM.S351125] [Reference Citation Analysis]
107 Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M, Dold C, Provine NM, Aboagye J, Fowler J, Silk SE, Alderson J, Aley PK, Angus B, Berrie E, Bibi S, Cicconi P, Clutterbuck EA, Chelysheva I, Folegatti PM, Fuskova M, Green CM, Jenkin D, Kerridge S, Lawrie A, Minassian AM, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Song R, Snape MD, Tarrant R, Voysey M, Watson MEE, Douglas AD, Hill AVS, Gilbert SC, Pollard AJ, Lambe T; Oxford COVID Vaccine Trial Group. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 2021;27:270-8. [PMID: 33335323 DOI: 10.1038/s41591-020-01194-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 95] [Article Influence: 41.5] [Reference Citation Analysis]